Original-Research
Nynomic AG (von NuWays AG): BUY
Für Sie zusammengefasst
- Q1 sales grew 8% yoy and EBIT turned positive
- Order backlog €55.6m up 23% and intake €32.9m
- Confirmed BUY and PT increased to EUR 25 target
|
Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG |
| Company Name: | Nynomic AG |
| ISIN: | DE000A0MSN11 |
| Reason for the research: | Update |
| Recommendation: | BUY |
| Target price: | EUR 25 |
| Target price on sight of: | 12 months |
| Last rating change: | |
| Analyst: | Christian Sandherr |
Q1 prelims: Inflection point reached; PT Up
Q1 preliminary sales grew 8% yoy to € 22.3m, marking the first quarter with top-line growth since Q1 2024. EBIT turned positive at € 0.1m versus € -0.9m a year ago, supported by the improved top-line and confirming that the NyFIT2025 efficiency program is translating into structural margin recovery. The annualised savings of approximately € 5m are now visibly flowing through the P&L, and with the group structure leaner and the cost base materially reduced, the operative platform is well positioned to leverage revenue growth into profitability at an accelerating rate through the year.
Diskutieren Sie über die enthaltenen Werte
Verfasst von EQS Group AG
1 im Artikel enthaltener WertIm Artikel enthaltene Werte

